메뉴 건너뛰기




Volumn 40, Issue 1, 2012, Pages 6-17

A semiphysiologically based pharmacokinetic modeling approach to predict the dose-exposure relationship of an antiparasitic prodrug/active metabolite pair

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; PAFURAMIDINE;

EID: 84455194130     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.040063     Document Type: Article
Times cited : (20)

References (32)
  • 1
    • 44649162440 scopus 로고    scopus 로고
    • Are highly lipophilic volatile compounds expected to bioaccumulate with repeated exposures?
    • Andersen ME, Reddy MB, and Plotzke KP (2008) Are highly lipophilic volatile compounds expected to bioaccumulate with repeated exposures? Toxicol Lett 179:85-92.
    • (2008) Toxicol Lett , vol.179 , pp. 85-92
    • Andersen, M.E.1    Reddy, M.B.2    Plotzke, K.P.3
  • 3
    • 78349310347 scopus 로고    scopus 로고
    • Potential new drugs for human African trypanosomiasis: Some progress at last
    • Barrett MP (2010) Potential new drugs for human African trypanosomiasis: some progress at last. Curr Opin Infect Dis 23:603-608.
    • (2010) Curr Opin Infect Dis , vol.23 , pp. 603-608
    • Barrett, M.P.1
  • 5
    • 0030591850 scopus 로고    scopus 로고
    • Anti-pneumocystis activity of bis-amidoximes and bis-O-alkylamidoximes prodrugs
    • DOI 10.1016/S0960-894X(96)00557-4, PII S0960894X96005574
    • Boykin DW, Kumar A, Hall JE, Bender BC, and Tidwell RR (1996) Anti-Pneumocystis carinii activity of bis-amidoximes and bis-O-alkylamidoxime prodrugs. Bioorg Med Chem 6:3017-3020. (Pubitemid 27015904)
    • (1996) Bioorganic and Medicinal Chemistry Letters , vol.6 , Issue.24 , pp. 3017-3020
    • Boykin, D.W.1    Kumar, A.2    Hall, J.E.3    Bender, B.C.4    Tidwell, R.R.5
  • 10
    • 3543026365 scopus 로고    scopus 로고
    • Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes
    • DOI 10.1023/B:PHAM.0000026429.12114.7d
    • Ito K and Houston JB (2004) Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res 21:785-792. (Pubitemid 39011301)
    • (2004) Pharmaceutical Research , vol.21 , Issue.5 , pp. 785-792
    • Ito, K.1    Houston, J.B.2
  • 11
    • 17644381224 scopus 로고    scopus 로고
    • Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
    • DOI 10.1007/s11095-004-9015-1
    • Ito K and Houston JB (2005) Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm Res 22:103-112. (Pubitemid 40558152)
    • (2005) Pharmaceutical Research , vol.22 , Issue.1 , pp. 103-112
    • Ito, K.1    Houston, J.B.2
  • 13
    • 0030918716 scopus 로고    scopus 로고
    • Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
    • DOI 10.1021/js960440h
    • Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, and Coassolo P (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci 86:584-590. (Pubitemid 27203406)
    • (1997) Journal of Pharmaceutical Sciences , vol.86 , Issue.5 , pp. 584-590
    • Lave, T..1    Dupin, S.2    Schmitt, C.3    Chou, R.C.4    Jaeck, D.5    Coassolo, P..6
  • 15
    • 0032428485 scopus 로고    scopus 로고
    • Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics
    • Lin JH (1998) Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab Dispos 26:1202-1212.
    • (1998) Drug Metab Dispos , vol.26 , pp. 1202-1212
    • Lin, J.H.1
  • 17
    • 62949246259 scopus 로고    scopus 로고
    • Efficacy of the novel diamidine compound 2,5-bis(4-amidinophenyl)- furan-bis-O-methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration
    • Mdachi RE, Thuita JK, Kagira JM, Ngotho JM, Murilla GA, Ndung'u JM, Tidwell RR, Hall JE,and Brun R (2009) Efficacy of the novel diamidine compound 2,5-bis(4-amidinophenyl)- furan-bis-O-methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration. Antimicrob Agents Chemother 53:953-957.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 953-957
    • Mdachi, R.E.1    Thuita, J.K.2    Kagira, J.M.3    Ngotho, J.M.4    Murilla, G.A.5    Ndung'U, J.M.6    Tidwell, R.R.7    Hall, J.8    Brun, R.9
  • 18
    • 34249037167 scopus 로고    scopus 로고
    • Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N- methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride)
    • DOI 10.1124/dmd.106.013391
    • Midgley I, Fitzpatrick K, Taylor LM, Houchen TL, Henderson SJ, Wright SJ, Cybulski ZR, John BA, McBurney A, Boykin DW, et al. (2007) Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/ antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride). Drug Metab Dispos 35:955-967. (Pubitemid 46798606)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.6 , pp. 955-967
    • Midgley, I.1    Fitzpatrick, K.2    Taylor, L.M.3    Houchen, T.L.4    Henderson, S.J.5    Wright, S.J.6    Cybulski, Z.R.7    John, B.A.8    McBurney, A.9    Boykin, D.W.10    Trendler, K.L.11
  • 19
    • 49649113402 scopus 로고    scopus 로고
    • Bayesian calibration of a physiologically based pharmacokinetic/ pharmacodynamic model of carbaryl cholinesterase inhibition
    • Nong A, Tan YM, Krolski ME, Wang J, Lunchick C, Conolly RB, and Clewell HJ 3rd (2008) Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition. J Toxicol Environ Health A 71:1363-1381.
    • (2008) J Toxicol Environ Health A , vol.71 , pp. 1363-1381
    • Nong, A.1    Tan, Y.M.2    Krolski, M.E.3    Wang, J.4    Lunchick, C.5    Conolly, R.B.6    Clewell III, H.J.7
  • 21
    • 52949140158 scopus 로고    scopus 로고
    • Formed and preformed metabolites: Facts and comparisons
    • Pang KS, Morris ME, and Sun H (2008) Formed and preformed metabolites: facts and comparisons. J Pharm Pharmacol 60:1247-1275.
    • (2008) J Pharm Pharmacol , vol.60 , pp. 1247-1275
    • Pang, K.S.1    Morris, M.E.2    Sun, H.3
  • 22
    • 34248680469 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetics in drug development and regulatory science: A workshop report (Georgetown University, Washington, DC, May 29-30, 2002)
    • Rowland M, Balant L, and Peck C (2004) Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002). AAPS Pharm Sci 6:E6.
    • (2004) AAPS Pharm Sci , vol.6
    • Rowland, M.1    Balant, L.2    Peck, C.3
  • 24
    • 77954362516 scopus 로고    scopus 로고
    • Sandwich-cultured hepatocytes: An in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
    • Swift B, Pfeifer ND, and Brouwer KL (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446-471.
    • (2010) Drug Metab Rev , vol.42 , pp. 446-471
    • Swift, B.1    Pfeifer, N.D.2    Brouwer, K.L.3
  • 28
    • 70349334612 scopus 로고    scopus 로고
    • New treatment option for second-stage African sleeping sickness: In vitro and in vivo efficacy of aza analogs of DB289
    • Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, and Brun R (2009) New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 53:4185-4192.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 4185-4192
    • Wenzler, T.1    Boykin, D.W.2    Ismail, M.A.3    Hall, J.E.4    Tidwell, R.R.5    Brun, R.6
  • 29
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
    • Wu CY and Benet LZ (2005) Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
    • (2005) Pharm Res , vol.22 , pp. 11-23
    • Wu, C.Y.1    Benet, L.Z.2
  • 30
    • 79955021414 scopus 로고    scopus 로고
    • Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: Comparison of two preclinical hepatic models
    • Yan GZ, Brouwer KL, Pollack GM, Wang MZ, Tidwell RR, Hall JE, and Paine MF (2011) Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models. J Pharmacol Exp Ther 337:503-512.
    • (2011) J Pharmacol Exp Ther , vol.337 , pp. 503-512
    • Yan, G.Z.1    Brouwer, K.L.2    Pollack, G.M.3    Wang, M.Z.4    Tidwell, R.R.5    Hall, J.E.6    Paine, M.F.7
  • 31
    • 0036845742 scopus 로고    scopus 로고
    • Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl) furan across Caco-2 cell monolayers via its methylamidoxime prodrug
    • DOI 10.1023/A:1020957430400
    • Zhou L, Lee K, Thakker DR, Boykin DW, Tidwell RR, and Hall JE (2002) Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoxime prodrug. Pharm Res 19:1689-1695. (Pubitemid 35305521)
    • (2002) Pharmaceutical Research , vol.19 , Issue.11 , pp. 1689-1695
    • Zhou, L.1    Lee, K.2    Thakker, D.R.3    Boykin, D.W.4    Tidwell, R.R.5    Hall, J.E.6
  • 32
    • 1942516882 scopus 로고    scopus 로고
    • Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry
    • DOI 10.1002/jms.591
    • Zhou L, Thakker DR, Voyksner RD, Anbazhagan M, Boykin DW, Hall JE, and Tidwell RR (2004) Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furanbis- O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 39:351-360. (Pubitemid 38515348)
    • (2004) Journal of Mass Spectrometry , vol.39 , Issue.4 , pp. 351-360
    • Zhou, L.1    Thakker, D.R.2    Voyksner, R.D.3    Anbazhagan, M.4    Boykin, D.W.5    Hall, J.E.6    Tidwell, R.R.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.